Atazanavir + Cobicistat
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Atazanavir
atazanavir - Cobicistat
cobicistat
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| EVOTAZAUCAESEUGBUS | 300 mg / 150 mg | BRISTOL-MYERS SQUIBB CANADA |
| Atazanavir 300mg / Cobicistat 150mg tabletsAUESGB | 300 mg / 150 mg | Bristol-Myers Squibb Australia Pty Ltd |
| atazanavir and cobicistatUS | 300 mg / 150 mg | E.R. Squibb & Sons, L.L.C. |
| cobicistat + atazanavirAU | — | — |
| EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottleAU | 150 mg / 300 mg | Bristol-Myers Squibb Australia Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- ES · EVOTAZ · 1 products · record
- GB · EVOTAZ · 1 products · record
- US · EVOTAZ · 1 products · record
- AU · EVOTAZ · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.